Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,719
archived clinical trials in
Diabetic Neuropathy

Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#127)
mi
from
Winston-Salem, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#127)
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#124)
mi
from
Cincinnati, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#124)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Columbus, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#148)
mi
from
Parma Heights, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#148)
mi
from
Parma Heights, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#101)
mi
from
Philadelphia, PA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#101)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#149)
mi
from
Pittsburgh, PA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#149)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#146)
mi
from
Providence, RI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#146)
mi
from
Providence, RI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Chattanooga, TN
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Nashville, TN
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#119)
mi
from
Dallas, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#119)
mi
from
Dallas, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Midland, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Midland, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#132)
mi
from
Salt Lake City, UT
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#132)
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#107)
mi
from
Burlington, VT
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#107)
mi
from
Burlington, VT
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#129)
mi
from
Charlottesville, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#129)
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Hampton, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Hampton, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#144)
mi
from
Richmond, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#144)
mi
from
Richmond, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#121)
mi
from
Spokane, WA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#121)
mi
from
Spokane, WA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#122)
mi
from
Milwaukee, WI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#122)
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#205)
mi
from
Camperdown,
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#205)
mi
from
Camperdown,
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Compass Research LLC
mi
from
Orlando, FL
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Beth Israel Deaconess
mi
from
Boston, MA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Beth Israel Deaconess
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Neurosciences Institute, Albany Medical College
mi
from
Albany, NY
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Neurosciences Institute, Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Mount Sinai Hospital
mi
from
New York, NY
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
University of Oklahoma Harold Hamm Diabetes Center
mi
from
Oklahoma City, OK
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
University of Oklahoma Harold Hamm Diabetes Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Houston Neurocare
mi
from
Houston, TX
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Houston Neurocare
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
University of Utah
mi
from
Salt Lake City, UT
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
East Virginia Medical School Strelitz Diabetes Center
mi
from
Norfolk, VA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
East Virginia Medical School Strelitz Diabetes Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Palm Beach Neurological Center,
mi
from
Palm Beach Gardens, FL
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Palm Beach Neurological Center,
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Northwestern University
mi
from
Chicago, IL
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Methodist Hospital
mi
from
Houston, TX
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Rainier Clinical Research
mi
from
Seattle, WA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Rainier Clinical Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
Seoul National University Bundang Hospital
mi
from
Seongnam,
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Seoul National University Bundang Hospital
mi
from
Seongnam,
Click here to add this to my saved trials
Matrix Metalloproteinases and Diabetic Nephropathy
Matrix Metalloproteinases and Diabetic Nephropathy
Status: Enrolling
Updated:  4/12/2016
Arkansas Children's Hospital/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Matrix Metalloproteinases and Diabetic Nephropathy
Matrix Metalloproteinases and Diabetic Nephropathy
Status: Enrolling
Updated: 4/12/2016
Arkansas Children's Hospital/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tucson, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Chino, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Fresno, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
National City, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
San Francisco, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials